These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Actor-network theory: a tool to support ethical analysis of commercial genetic testing. Williams-Jones B; Graham JE New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034 [TBL] [Abstract][Full Text] [Related]
3. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards. Malinowski MJ; Blatt RJ Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901 [TBL] [Abstract][Full Text] [Related]
4. Whither morality in genetic tests? Burgess MM Health Law Rev; 2001; 9(3):3-9. PubMed ID: 15706713 [No Abstract] [Full Text] [Related]
5. What's in a test? Nat Methods; 2009 Nov; 6(11):783. PubMed ID: 19885990 [No Abstract] [Full Text] [Related]
6. Ethics and human genetics. Chapman AR Annu Soc Christ Ethics; 1998; 18():293-303. PubMed ID: 12528716 [No Abstract] [Full Text] [Related]
7. Creating needs? A review of survey data and concerns relevant to the commercialization of genetic testing. Caulfield T; Wertz D Community Genet; 2001; 4(2):68-76. PubMed ID: 12751481 [TBL] [Abstract][Full Text] [Related]
8. Private genetic testing in Canada: a summary. Williams-Jones B Health Law Rev; 2001; 9(3):10-3. PubMed ID: 15706712 [No Abstract] [Full Text] [Related]
9. Survey confirms fears about licensing of genetic tests. Schissel A; Merz JF; Cho MK Nature; 1999 Nov; 402(6758):118. PubMed ID: 10646997 [No Abstract] [Full Text] [Related]
10. Social contract theory and just decision making: lessons from genetic testing for the BRCA mutations. Williams-Jones B; Burgess MM Kennedy Inst Ethics J; 2004 Jun; 14(2):115-42. PubMed ID: 15281186 [TBL] [Abstract][Full Text] [Related]
11. [Are we threatened by misuse? Discreditation of medical genetics]. Goetz P; Foretová L; Macek M; Brdicka R; Jüttnerová V; Franková V; Horínová V; Payne J; Hach P Cas Lek Cesk; 2008; 147(3):159-61. PubMed ID: 18401982 [No Abstract] [Full Text] [Related]
12. The informed gatekeeper?: a commentary on genetic tests, marketing pressure and the role of primary care physicians. Caulfield TA Health Law Rev; 2001; 9(3):14-8. PubMed ID: 15706711 [No Abstract] [Full Text] [Related]
13. Ethics and genetics in Latin America. Rivera-Lopez E Dev World Bioeth; 2002 May; 2(1):11-20. PubMed ID: 12872766 [TBL] [Abstract][Full Text] [Related]
15. A conceptual framework for genetic policy: comparing the medical, public health, and fundamental rights models. Andrews LB Wash Univ Law Q; 2001; 79(152):221-85. PubMed ID: 16211786 [No Abstract] [Full Text] [Related]
16. From innovation to successful commercialization: assessing value and investment--does the equation make sense? Toneguzzo F Surgery; 2008 Feb; 143(2):165-8. PubMed ID: 18242328 [No Abstract] [Full Text] [Related]
17. Genetic testing policy issues for the next millennium: abstract of remarks. Organization for Economic Cooperation and Development (OECD) J Biolaw Bus; 2001; 4(3):37-50. PubMed ID: 12962104 [No Abstract] [Full Text] [Related]